Journal of Medicinal Chemistry · 2020 · 29 citations · 17 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular PharmacologyEnzyme InhibitionHit-to-lead OptimizationTopoisomerase InhibitorsAnticancer ActivityAnticancer ChemotherapyAntiproliferative AgentsBlood-brain Barrier PermeabilityDna CleavageDna Topoisomerase Ii InhibitionTopoisomerase Ii FunctionTopoisomerase Ii Inhibitors
= 120 μM for the anticancer drug etoposide] with excellent metabolic stability and solubility. This new compound also shows ~100-fold selectivity for topoIIα over topoβ, a broad antiproliferative activity toward cultured human cancer cells, a favorable in vivo pharmacokinetic profile, and the ability to penetrate the blood-brain barrier. Thus, ARN-21934 is a highly promising lead for the development of novel and potentially safer topoII-targeted anticancer drugs.
17
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Chyuan-Chuan Wu, Tsai‐Kun Li, Lynn Farh et al. · Science · 2011 · 514 citations